Loading…
Product type
Bosutinib is a small molecule tyrosine kinase inhibitor primarily used in the treatment of chronic myelogenous leukemia (CML). It works by inhibiting the activity of specific proteins that promote cancer cell growth, thereby slowing down or stopping the proliferation of cancerous cells. Bosutinib is synthesized through chemical processes involving various organic compounds, resulting in a potent therapeutic agent for targeted cancer therapy.
| Chemical formula | C24H26ClN5O2 |
| Molecular weight | 465.95 g/mol |
| Purity | Typically ≥ 98% |
| Form | Powder or crystalline form |
| Storage conditions | Store in a cool, dry place, away from light |
When selecting Bosutinib as an active pharmaceutical ingredient, buyers should consider the required purity levels and the specific formulation needs for their applications. It's important to specify any relevant certifications, such as Good Manufacturing Practice (GMP) compliance, and to discuss the desired quantities, as bulk purchasing may affect pricing and availability. Additionally, understanding the stability and storage requirements is crucial for maintaining product efficacy.
Get quotes for Bosutinib
Tell us your requirement — quantity, specs and timeline — and our team sources verified manufacturers and brings you the best quote.
Bosutinib is primarily used to treat chronic myelogenous leukemia (CML).
It is usually administered orally in tablet form.
Common side effects include diarrhea, nausea, and fatigue.
Bosutinib is a brand name drug, but generic versions may be available.
Consider purity, certifications, and supplier reliability.
Yes, it may be used in combination with other cancer treatments, but consult a healthcare provider.